Literature DB >> 21171187

Bronchoscopic findings in a child with pandemic novel H1N1 influenza A and methicillin-resistant Staphylococcus aureus.

Jack K Sharp1, James Hereth, Joseph Fasanello.   

Abstract

The spectrum of disease with pandemic novel H1N1 influenza A (2009) virus ranges from non-febrile, mild upper respiratory tract infection to severe or fatal pneumonia. We report the bronchoscopic findings associated with a fatal case of H1N1 influenza A associated with co-infection with methicillin-resistant Staphylococcus aureus (MRSA) in a previously healthy child, which were more severe than those previously described as associated with seasonal influenza infection alone. The severity of the airway pathology seen on bronchoscopy in this patient may be due to a unique effect of the H1N1 influenza A virus or may be as a result of a destructive synergism between this virus and bacteria such as MRSA.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21171187     DOI: 10.1002/ppul.21306

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  3 in total

1.  Successful treatment of pleural empyema and necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus infection following influenza A virus infection: A case report and literature review.

Authors:  Chunjiao Han; Tongqiang Zhang; Yidi Zhao; Lili Dong; Xiaole Li; Jiafeng Zheng; Wei Guo; Yongsheng Xu; Chunquan Cai
Journal:  Front Pediatr       Date:  2022-08-26       Impact factor: 3.569

2.  A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus.

Authors:  Jun Dai; Decui Pei; Baoning Wang; Yu Kuang; Laifeng Ren; Kang Cao; Bin Zuo; Jingjing Shao; Sha Li; Zhonghua Jiang; Hong Li; Mingyuan Li
Journal:  Virol J       Date:  2013-01-31       Impact factor: 4.099

3.  The Important Role of Endoscopy in Management of Pediatric Pseudomembranous Necrotizing Tracheitis.

Authors:  Xiling Wu; Lei Wu; Zhimin Chen
Journal:  Front Pediatr       Date:  2020-07-09       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.